Skip to main navigation Skip to search Skip to main content

Phase 3 Clinical Trials in Dupuytren's Disease

Project: Research

Project Details

StatusFinished
Effective start/end date12/19/0602/28/11

Funding

  • Auxilium Pharmaceuticals: $197,463.74